Zelba, Henning http://orcid.org/0000-0003-1391-0874
Bochem, Jonas
Pawelec, Graham
Garbe, Claus
Wistuba-Hamprecht, Kilian
Weide, Benjamin
Funding for this research was provided by:
Bristol-Myers Squibb
Novartis Pharma
Roche
Merck Sharp and Dohme
Klaus Tschira Stiftung (00.316.2017)
Article History
Received: 9 January 2018
Accepted: 7 September 2018
First Online: 14 September 2018
Compliance with ethical standards
:
: All patients/donors gave written informed consent for biobanking, and use of biomaterials and clinical data for scientific purposes. This study was approved by the ethics committee in Tübingen (Ethik-Kommission an der Medizinischen Fakultät der Eberhard-Karls-Universität und am Universitätsklinikum Tübingen; approvals 490/2014BO1 and 792/2016BO2).
: C. Garbe reports receiving commercial research grants from Bristol-Myers Squibb, Novartis, and Roche; and is a consultant/advisory board member for Amgen, Bristol-Myers Squibb, Merck Sharp & Dohme, Novartis, and Roche. B. Weide reports receiving commercial research grants from, is a consultant/advisory board member for, and reports receiving travel reimbursement from Bristol-Myers Squibb and Merck Sharp & Dohme. No potential conflicts of interest were disclosed by the other authors.